Jose Merino, HRS 2019 – Oesophageal Damage During Atrial Fibrillation Ablation
At Heart Rhythm 2019, we spoke with Dr Jose Merino (Director, Arrhythmia and Robotic Electrophysiology Unit, Hospital General Universitario La Paz, Madrid, Spain) about the current unmet needs in atrial fibrillation ablation, and the potential causes and ways to minimise the risk of oesophageal damage during atrial fibrillation ablation.
Speaker’s Disclosures: Jose Merino has received speaker’s, educational and research services fees from Abbott, Bayer, Biotronik, Boston Scientific, Cardiome, Daiichi, Medtronic, Microport and Sanofi.
1. What are the current unmet needs in atrial fibrillation ablation? (0:06)
2. What are the potential causes for oesophageal damage during ablation? (1:03)
3. How can these risks be minimised in routine practice? (2:27)
4. What are your highlights from Heart Rhythm 2019? (3:45)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Atrial Fibrillation
World Heart Rhythm Week: Considerations and challenges in arrhythmia
It’s World Heart Rhythm Week 2023! Learn about key considerations for managing and treating arrhythmias, ongoing research and the importance of seeking medical advice for syncope.
Bruce Wilkoff, EHRA 2023: The AdaptResponse trial, synchronized left ventricular pacing for heart failure with left bundle branch block
The AdaptResponse trial was designed to assess two methods of restoring resynchronization to the heart in patients with heart failure with left bundle branch block. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the design of the AdaptResponse trial, the outcomes as well as the clinical […]
Bruce Wilkoff, EHRA 2023: An overview of cardiac resynchronization therapy for patients with heart failure
Cardiac resynchronization therapy is designed to restore the electrical activation in a more natural way in patients with heart failure. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the treatment paradigm with focus on cardiac resynchronization therapy for patients with heart failure. Bruce Wilkoff presented an […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!